Background While ICD therapy reduction programming strategies are recommended in
current multi-society guidelines, concerns remain about a possible trade-off between the …

Background Inappropriate therapy is a common adverse effect in patients with an
implantable cardioverter–defibrillator (ICD) that may be prevented by appropriate …

Background We sought to examine the mortality impact of appropriate implantable
cardioverter defibrillator (ICD) therapy between patients who received ICD for primary …

Abstract The 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal
Implantable Cardioverter-Defibrillator Programming and Testing provided guidance on …

Introduction Several implantable cardioverter defibrillators (ICD) programming strategies are
applied to minimize ICD therapy, especially unnecessary therapies from supraventricular …

Background—Underuse of implantable defibrillators has been previously noted in patients
at risk for sudden cardiac death, as well as for survivors of sudden cardiac death. We sought …

Background—Patients who receive implantable cardioverter defibrillator therapies are at
higher risk of death versus those who do not. Programmed settings to reduce nonessential …

Implantable cardioverter-defibrillator (ICD) programming influences the rate of ICD
therapies. Randomized controlled trials and prospective studies have shown a mortality …

In 2011, Atul Gawande published The Checklist Manifesto: How to Get Things Right, in
which he profoundly stated that,“the volume and complexity of what we know has exceeded …

Background—Although implantable cardioverter-defibrillators (ICDs) reduce mortality in
primary prevention patients with left ventricular systolic dysfunction, recent studies have …